Since loss of PAI-1 activity has been shown to be protective against L-NAME-induced pathologies, we evaluated whether genetic deficiency or pharmacologic inhibition of PAI-1 would attenuate L-NAME-induced emphysema. Here, SERPINE1 is linked to pulmonary emphysema.